Iwona Gawron, Magdalena Łoboda, Dorota Babczyk, Inga Ludwin, Paweł Basta, Kazimierz Pityński, Artur Ludwin
{"title":"Endometrial cancer and hyperplasia rate in women before menopause with abnormal uterine bleeding undergoing endometrial sampling.","authors":"Iwona Gawron, Magdalena Łoboda, Dorota Babczyk, Inga Ludwin, Paweł Basta, Kazimierz Pityński, Artur Ludwin","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Abnormal uterine\nbleeding (AUB) is the most common\nsymptom of endometrial cancer (EC)\nand endometrial hyperplasia with\n(AH) or without (EH) atypia. Risk of\nmalignancy and hyperplasia is significantly\nlower in premenopausal\nthan in postmenopausal women. Only\n10% of EC occurs before menopause.\nObesity and age are well-recognized\nrisk factors of endometrial cancer.\nEndometrial sampling is recommended\nin women at high risk of endometrial\nmalignancy. The primary objective\nwas to determine the incidence\nof EC, AH and EH in premenopausal\nwomen undergoing dilation and curettage\n(D&C) because of AUB. Additional\nobjective of the study was\nto estimate the risk of EC and AH in\noverweight and obese women with\ntwo types of AUB: heavy menstrual\nbleeding (AUB-HMB) and intermenstrual\nbleeding (AUB-IMB), according\nto PALM-COEIN classification.</p><p><strong>Material and methods: </strong>Retrospective\nstudy in the population of women\nundergoing D&C in tertiary hospital\nbecause of AUB between Jan-2016\nand Dec-2016. The incidence of EC,\nAH, EH was established. The influence\nof the variables: age, BMI, AUBHMB/\nAUB-IMB on the occurrence of\nabnormal histology (EC, AH, EH) was\nevaluated. Finally, the model built by\nusing backward stepwise regression\nand mechanism of v-fold cross-validation,\nshowed no statistically significant\nrelationship.</p><p><strong>Results: </strong>EC was detected in 2/213\ncases (0.9%; 95% CI 0.0003 to 0.036),\nAH in 3/213 cases (1.4%), giving a total\nof 5/213 (2.3%) women with AH or\nEC. EH was detected in 16/213 (7.5%)\nwomen. High BMI raises the chance of\nAH diagnosis: OR 1.16 (95% CI 1.05-\n1.28). The presence of HMB compared\nto IMB reduces the chance of EH: OR\n0.24 (95% CI 0.07-0.9). IMB increases\nthe chance for the diagnosis of EH 4.11 times compared to\nHMB (OR 4.1, 95% CI 1.1-14.9; p = 0.016).</p><p><strong>Conclusions: </strong>EC in premenopausal women with AUB\nundergoing D&C is rare. There is a need to search for\nmore effective methods of selection of patients than commonly\nused. Age and BMI do not seem to be factors that\nshould be used to select patients.</p>","PeriodicalId":21148,"journal":{"name":"Przeglad lekarski","volume":"74 4","pages":"139-43."},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Przeglad lekarski","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Abnormal uterine
bleeding (AUB) is the most common
symptom of endometrial cancer (EC)
and endometrial hyperplasia with
(AH) or without (EH) atypia. Risk of
malignancy and hyperplasia is significantly
lower in premenopausal
than in postmenopausal women. Only
10% of EC occurs before menopause.
Obesity and age are well-recognized
risk factors of endometrial cancer.
Endometrial sampling is recommended
in women at high risk of endometrial
malignancy. The primary objective
was to determine the incidence
of EC, AH and EH in premenopausal
women undergoing dilation and curettage
(D&C) because of AUB. Additional
objective of the study was
to estimate the risk of EC and AH in
overweight and obese women with
two types of AUB: heavy menstrual
bleeding (AUB-HMB) and intermenstrual
bleeding (AUB-IMB), according
to PALM-COEIN classification.
Material and methods: Retrospective
study in the population of women
undergoing D&C in tertiary hospital
because of AUB between Jan-2016
and Dec-2016. The incidence of EC,
AH, EH was established. The influence
of the variables: age, BMI, AUBHMB/
AUB-IMB on the occurrence of
abnormal histology (EC, AH, EH) was
evaluated. Finally, the model built by
using backward stepwise regression
and mechanism of v-fold cross-validation,
showed no statistically significant
relationship.
Results: EC was detected in 2/213
cases (0.9%; 95% CI 0.0003 to 0.036),
AH in 3/213 cases (1.4%), giving a total
of 5/213 (2.3%) women with AH or
EC. EH was detected in 16/213 (7.5%)
women. High BMI raises the chance of
AH diagnosis: OR 1.16 (95% CI 1.05-
1.28). The presence of HMB compared
to IMB reduces the chance of EH: OR
0.24 (95% CI 0.07-0.9). IMB increases
the chance for the diagnosis of EH 4.11 times compared to
HMB (OR 4.1, 95% CI 1.1-14.9; p = 0.016).
Conclusions: EC in premenopausal women with AUB
undergoing D&C is rare. There is a need to search for
more effective methods of selection of patients than commonly
used. Age and BMI do not seem to be factors that
should be used to select patients.